The AFL has released a statement regarding the status of AOD-9604 AFL general counsel Andrew Dillon has made the following statement in relation to the status of AOD-9604: "When the Australian Crime Commission report was released in February this year, the report indicated AOD-9604 was not a banned substance
Patients with pernicious anaemia may therefore experience joint symptoms related to concurrent autoimmune conditions rather than the B12 deficiency itself
By prioritizing B12 intake, older adults can sustain their cognitive and physical health, leading to an improved quality of life
Tesofensine produced weight loss significantly greater than placebo and was more effective than any currently approved obesity drug at the time. Astrup et al., The Lancet Additional Findings: The majority of weight loss came from visceral fat and abdominal adiposity Lean body mass was preserved , unlike with most appetite suppressants Participants reported reduced hunger and better diet adherence Tesofensine significantly improved waist circumference , lipid profiles, and fasting glucose These findings have led to continued interest in Tesofensines use for body recomposition not just for general weight loss, but for fat-specific reduction without muscle sacrifice
Furthermore, elevated lactate concentrations were tentatively linked to the mitigation of pyruvate dehydrogenase (PDH) activity
These changes correlate with weight loss magnitude, particularly reduction in visceral adiposity and neck circumference